TALPHERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 0.00 shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 14.00K shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 19.40K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 14.00K shares 10-K · filed 2026-03-23 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-23 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | -875.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 0.00 shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 875.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 875.33K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-10 | 0.00 shares derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-12-31 | 0.00 shares derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | 0.00 shares 8-K · filed 2023-08-01 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 19.40K shares 10-K · filed 2022-03-10 | |
| 2020-12-31 | 0.00 shares 10-K · filed 2021-03-15 | |
| 2019-12-31 | 111.70K shares 10-K · filed 2020-03-16 | |
| 2018-12-31 | 135.38K shares 10-K · filed 2019-03-07 | |
| 2017-12-31 | 69.37K shares 10-K · filed 2018-03-09 | |
| 2015-12-31 | 938.50K shares 10-K · filed 2016-03-07 | |
| 2014-12-31 | 439.29K shares 10-K · filed 2015-03-13 | |
| 2013-12-31 | 431.22K shares 10-K · filed 2015-03-13 | |
| 2012-12-31 | 43.77K shares 10-K · filed 2015-03-13 | |
| 2011-12-31 | 69.77K shares 10-K · filed 2014-03-17 | |
| 2010-12-31 | 10.96K shares 10-K · filed 2013-03-12 | |
| 2009-12-31 | 21.61K shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |